T HE MAINTENANCE and control of normal testicular physiology and the process of spermatogenesis require endocrine regulation. FSH initiates and maintains various Sertoli cell functions associated with a more differentiated state of the cell. In addition, LH regulates androgen production by Leydig cells that acts to maintain spermatogenesis. Both Sertoli cells (1) and peritubular myoid cells (2) express androgen receptors. Androgens have been shown to act on peritubular cells in vitro to stimulate the production of a paracrine factor that can regulate Sertoli cell functions (3). This paracrine factor, termed PModS, modulates Sertoli cell functions in vitro to a greater extent than any individual regulatory agent previously examined, including FSH (4, 5). Two isoforms of PModS have been purified, PModS(A) and PModS(B), that have slightly different mol wt and the same apparent biological activities (4,5). The information available implies that PModS(A) is a processed form of PModS(B) with equivalent bioactivity. Therefore, use of the term PModS will refer to the actions of PModS(A) and/or PModS(B). The only active agent in PSP found to stimulate Sertoli cell function (e.g. transferrin production) is PModS (4, 5). The production of PModS by peritubular cells, therefore, represents a potentially important mode of androgen action in the testis that is postulated to be vital to maintain the process of spermatogenesis.
Both FSH and PModS influence various Sertoli cell functions associated with the differentiation of the cell. One major differentiated function is the production of transferrin. Transferrin is synthesized and secreted by Sertoli cells to transport iron to the developing germinal cells sequestered by the blood-testis barrier (6). The secretion of transferrin provides a biochemical marker to assess the responsiveness of Sertoli cells to regulatory agents in vitro. PModS increases transferrin secretion by Sertoli cells to a greater extent than FSH alone and to the same extent as the combination of FSH, insulin, retinol, and testosterone (FIRT). The combination of PModS and FIRT increases Sertoli cell transferrin secretion in an additive fashion (5). This implies that PModS may act through a different mechanism of action than any of the individual agents in FIRT.
The actions of FSH on Sertoli cell functions are mediated by CAMP and an increase in adenylate cyclase activity (7, 8) . Analogs of CAMP mimic the actions of FSH on Sertoli functions (9, 10). In addition, FSH may influence calcium homeostasis in Sertoli cells (11). In contrast, PModS does not alter CAMP levels in Sertoli cells, but it does increase cGMP levels (5). The current study investigates the pharmacology of PModS and the potential involvement of several common signal transduction pathways.
Materials and Methods
Cell preparation and culture Center, Dallas, TX) and iodinated CAMP or cGMP for 14-18 h at 4 C, followed by a l-h precipitation at 4 C with bovine plasma (Sigma) and 12% polyethylene glycol. Complexed antibody was centrifuged, and radioactivity in the pellets was determined.
Data were normalized to Sertoli cell protein at the time of cellular sonication.
Guanylate cycluse assay
Cell fractions were prepared from Sertoli cells cultured for 2 days in control medium or from cells treated with the appropriate agents for the indicated times. Cells were suspended and sonicated in a solution containing 20 mu HEPES (pH 7.4), 1 rn~ EDTA, 0.25 M sucrose, 1 mu benzamidine, 1 mM dithiotheitol, and 0.5 mu 1-methyl-3-isobutylxanthine. Membrane and cytosol fractions were obtained after centrifugation for 30 min,at 400,000 x g. Forty micrograms of membrane protein or cytosol protein and 100 rg total cellular protein were incubated for 10 min at 36 C in a total volume of 0.15 ml containing 20 mu HEPES (pH 7.4), 1 mu MnClr, 0.2 mu 1-methyl-3-isobutylxanthine, and 0.1 mt.,r GTP. Reactions were stopped by the addition of 1 vol HCIOl (0 
Results
The influence of PModS and FSH on Sertoli cell cyclic nucleotide levels was examined. Sertoli cells were cultured for 2 days in the absence of regulatory agents, then treated with FSH or PModS. The concentration of FSH (100 q/ml) used has previously been shown to be a maximal effective concentration to stimulate Sertoli cells, and dose-response curves provide an E&o of approximately 10 q/ml with the current experimental conditions (5, 14) . A 60-n-tin FSH treatment increased CAMP levels dramatically in Sertoli cells. PSP and purified PModS did not alter CAMP levels in Sertoli cells (Fig. 1) . In contrast, PSI' and PModS(B) elevated Sertoli cell cGMP levels to a small, but significant, extent after 60 min (Fig. 1) (Table l) , PModS(B) elevated cGMP levels after l-and 72-h treatments, and PModS(A) increased cGMP levels after 72 h. FSH had no influence on cGMP levels at any time point examined (Table 1 ). These studies suggest that the elevation in Sertoli cell cGMP levels by purified PModS occurs after a l-h treatment, and stimulation is maintained over the time course examined. As a comparison with PModS, the abilities of other regulatory agents to influence cGMP levels in the Sertoli cell were examined. ANF is an activator of a particulate form of Levels of cGMP in Sertoli cells cultured for various times in the absence (Control) or presence of 100 rig/ml FSH, 50 pg/ml PSP, 25 rig/ml PMODS A (PMSA), and 25 rig/ml PMODS B (PMSB) are shown. Maximal stimulating concentrations of the agents were used, as described in Materials and Methods.
Data are presented as a percentage of the control values (mean f SEM from seven different experiments performed in duplicate). a Statistically significant difference from the control (P < 0.05, determined by ANOVA). guanylate cyclase in a variety of tissues (21, 22) . Treatment of cultured Sertoli cells with ANF resulted in both a dosedependent (Fig. 3, bottom panel) and a time-dependent (data not shown) elevation of cGMP levels in Sertoli cells. cGMP levels were elevated to 2800% of control levels after a lomin treatment with 1 PM ANF. Sodium nitroprusside, an activator of soluble guanylate cyclase (23), elevated Sertoli cell cGMP to levels similar to those in ANF-treated cells (data not shown). The elevation of Sertoli cell cGMP levels by ANF was compared to that by PSI' (Fig. 3, top panel) . ANF caused a dramatic elevation of cGMP levels after 3 n-tin, whereas the increase in cGMP levels by PModS was marginal. After 72 h, PModS-treated cells had cGMP levels about 350% of the control value, whereas those in ANF-treated cells were not different from control levels.
The influence of PModS on guanylate cyclase activity was investigated as a potential cause of the increased cGMP levels. Sertoli cells were homogenized after 2 days of culture in control medium, and guanylate cyclase activity in the whole cell homogenate was determined. The linearity of the assay was determined with respect to time and quantity of enzyme. Neither PSP nor the purified forms of PModS increased guanylate cyclase activity (Fig. 4) . In contrast, both ANF and sodium nitroprusside increased guanylate cyclase activity. A particulate fraction of Sertoli cells was prepared, as described in Materials and Methods. Guanylate cyclase activity in the particulate fraction represented about 30% of the activity in the total homogenate. PModS did not increase the activity of particulate guanylate cyclase, whereas ANF did increase the activity of particulate guanylate cyclase (data not shown). In addition, Sertoli cells were cultured in the presence of PModS for 3-n-tin, l-h, or 72-h treatments, and guanylate cyclase activity was determined in whole cell homogenates. PModS did not increase guanylate cyclase activity in these homogenates (data not shown). These observations suggest that elevation of Sertoli cell cGMP levels by PModS does not occur though detectable direct activation of either the particulate or soluble forms of guanylate cyclase under the experimental conditions used. PModS also did not influence the level of cGMP-dependent phosphodiesterase (data not shown). Therefore, the hydrolysis of cGMP did not appear to be influenced by PModS.
The ability of increased levels of cGMP to stimulate a physiological response in Sertoli cells was investigated. Sertoli cells were cultured with agents that elevate cGMP levels to examine effects on transferrin secretion. Neither ANF, sodium nitroprusside, nor B-bromo-cGMP alone influenced transferrin secretion by cultured Sertoli cells (Fig. 5) . Under the same conditions, PSP and FIRT increased transfer+ secretion about 330% and 380%, respectively. ANF also did not alter the effects of PSP or FIRT on transferrin secretion (Fig. 5) . Similar results were obtained with sodium nitroprusside and B-bromo-cGMP in combination with PSP or FIRT (data not shown). These observations imply that the increase in cGMP levels associated with PSI' or PModS treatment of Sertoli cells does not appear to directly mediate the actions of PModS to increase transferrin secretion. As previously discussed, the only agent found in PSP to stimulate transferrin production is PModS (4).
To examine the influence of PModS on PI hydrolysis, Sertoli cells were cultured for 2 days in the absence of regulatory agents and then treated with PSP or fetal calf serum for a minimum of 15 set and a maximum of 5 min. PSP did not increase the levels of inositol trisphosphate (IP3), inositol bisphosphate (IPZ), or inositol monophosphate (IP,) in Sertoli cells at any time point examined (Fig. 6 ). Fetal calf serum, which served as a positive control, increased the levels of all three inositol phosphates. To confirm the results obtained with PSI', purified PModS was used to treat Sertoli cells at selected time points and was found not to influence PI hydrolysis (data not shown). Longer term treatments with PModS at 30 and 60 min also had no influence on PI metabolism (data not shown).
The ability of PModS to influence calcium uptake by Sertoli cells was examined. Sertoli cells were cultured in the absence of regulatory agents for 2 days, then were treated with either FSH or PSP in medium containing 45Ca2+. Neither FSH nor PSP altered calcium uptake by Sertoli cells after 10 min (Fig. 7) . A calcium ionophore, ionomycin, was used as a positive control and increased 45Ca2+ uptake after 10 min. Purified PModS was used to confirm the results obtained with PSP and was not found to influence 45Ca2+ uptake (data not shown). Preliminary experiments to investigate intracellular calcium mobilization used fura-2, as previously described with Sertoli cells (24). These studies were generously performed by Dr. David Handelsman, University of Sydney (Sydney, Australia). PModS had no effect on calcium mobilization, as measured by alterations in intracellular furafluorescence (data not shown). These results indicate that using phosphotyrosine antibodies (Fig. 8) . PModS was found to consistently increase and/or induce the levels of a 55-kilodalton protein in the cytosol preparation. Other proteins were also periodically influenced by PModS, but not reproducibly between experiments. The phosphotyrosine-containing proteins were not affected by PModS in the crude Sertoli cell membrane preparation. To extend these studies, Sertoli cells were incubated in the absence or presence of the tyrosine kinase inhibitor genistein (26). Genistein reduced the effect of PModS on Sertoli cells at a concentration of 3.5 PM (Fig. 9) . This same concentration of genistein inhibited the actions of FSH. At higher genistein concentrations of 17.5 PM (data not shown) and 35 PM, the ability of PModS to stimulate transferrin production was completely inhibited (Fig. 9) . Similar results were obtained with PSI' (data not shown). Calf serum (lo%, vol/vol) was used as a positive control and was not affected by the presence of genistein at any concentration used. Therefore, the Sertoli cells exposed to a 35-PM genistein concentration maintained viability and responsiveness to calf serum. These results imply that PModS can influence tyrosine phosphorylation of Sertoli cell proteins, and inhibition of tyrosine phosphorylation abolishes the activity of PModS on Sertoli cells. is a major regulator of Sertoli cell function and differentiation. In addition, PModS appears to have a mechanism of action different from that of the individual regulatory agents in FIRT. FSH is known to influence Sertoli cell functions though an elevation of CAMP levels, whereas previous studies demonstrated that PModS increases cGMP levels (5). For this reason, further analysis of the influence of PModS on cyclic nucleotide levels in Sertoli cells was initiated. Although PModS did not influence Sertoli cell CAMP levels, PModS did elevate cGMP levels. Previous reports have identified agents that elevate cGMP levels in whole testicular preparations or Leydig cells (27) (28) (29) . However, this is the first report of an alteration in Sertoli cell cGMP levels by any agent. PSP rapidly increased and maintained cGMP levels in Sertoli cells over an extended period. In contrast, purified PModS only mimicked PSI' actions after treatment of Sertoli cells for 1 h and longer. The difference between the effects of PSI' and PModS at 3 min is unclear. PSP may contain an alternate substance not associated with PModS that increases short term cGMP levels in Sertoli cells. The elevation in cGMP levels observed after 3-5 days of PModS treatment may be due to the long term effects of PModS on Sertoli cell differentiation.
Both ANF and sodium nitroprusside also increased cGMP levels in cultured Sertoli cells. ANF stimulates the activity of the particulate fraction of guanylate cyclase from Sertoli cells, whereas sodium nitroprusside stimulates the cytosolic form of the enzyme. In contrast, neither PSP nor purified PModS stimulated guanylate cyclase activity under the experimental conditions used. It is possible that PModS does stimulate guanylate cyclase activity in Sertoli cells, but that the response is dependent on a particular set of experimental conditions not present in the current study. The physiological significance of the effects of ANF and sodium nitroprusside on cGMP levels in Sertoli cells is unclear. Neither agent nor a cGMP analog altered transferrin secretion. Although PModS can stimulate cGMP levels in Sertoli cells, cGMP does not appear to directly mediate the actions of PModS. The increase in cGMP may be indirectly related to an induction of Sertoli cell differentiation by PModS.
Another second messenger reported to be influenced by FSH in Sertoli cells is calcium. Increased cellular calcium levels could provide a mechanism for the PModS-induced elevation of cGMP levels in Sertoli cells. Nitric oxide synthetase is a calcium-calmodulin-dependent enzyme that catalyses the oxidation of L-arginine to nitric oxide and citrulline (30). Thus, an elevation of cellular calcium levels could lead to the formation of nitric oxide with subsequent activation of the soluble form of guanylate cyclase and an elevation of cGMP levels. FSH has been shown to alter calcium homeostasis in Sertoli cells by increased uptake of extracellular calcium (31, 32). The inability of FSH to alter calcium uptake in the current study could be due to the sensitivity of the assays or the use of 20-day-old rat Sertoli cells, which are less responsive to FSH than younger lo-to 15-day-old rat Sertoli cells. PSI' does stimulate 20-day-old Sertoli cells, but did not alter calcium uptake by Sertoli cells. In addition, Endo. 1994 Vol134. No 1 preliminary studies using fluorescent procedures indicate that PModS does not influence intracellular calcium mobilization. Therefore, the actions of PModS do not appear to be mediated by calcium mobilization. Calcium homeostasis also may be influenced by elevation of IPB levels by PI hydrolysis and release of calcium from intracellular stores by IP3. In choroid plexus cells of the brain, serotonin activates PI hydrolysis and increases transferrin secretion. However, receptor antagonists that block PI hydrolysis in choroid plexus cells do not block transferrin production (33). PModS did not alter the levels of inositol phosphates in Sertoli cells. In addition, FSH inhibits PI hydrolysis in Sertoli cells (34), whereas the actions of FSH and PModS on transferrin secretion are additive. These observations suggest that inositol phosphates do not mediate the actions of PModS on Sertoli cells.
The current study demonstrates that PModS elevates Sertoli cell cGMP levels, but cGMP does not directly mediate the actions of PModS. Other Sertoli cell signaling pathways, such as CAMP levels, calcium uptake, and PI hydrolysis, were not influenced by PModS. These observations imply that PModS may influence an important phosphorylation event. PModS was found to influence the tyrosine phosphorylation of a Sertoli cell protein(s) after a 72-h treatment. Whether these tyrosine phosphorylations are associated with the increased differentiation of the cell and/or mediate the actions of PModS will require a detailed time-course study and characterization of these phosphorylated proteins. The tyrosine kinase inhibitor studies indicate that genistein inhibits the actions of PModS and support a potential role of tyrosine phosphorylation in the actions of PModS. A limitation to this study is that it is difficult to eliminate potential nonspecific effects of the kinase inhibitor on cell viability and hormone responsiveness.
Therefore, a more thorough investigation of the actions of PModS on protein phosphorylation is required to elucidate the pharmacology of PModS.
Recent findings suggest that PModS increases the expression of nuclear transcription factors (e.g. c-fos). This is further supported by the ability of an antisense oligonucleotide to cfos mRNA to partially inhibit the actions of PModS on Sertoli cell transferrin secretion (35). The ability of PModS to induce Sertoli cell differentiation is postulated to involve an alteration in the expression of unique transcription factors. Understanding the signal transduction pathway used by PModS to induce the expression of these transcription factors will provide insight into the molecular mechanisms that control Sertoli cell differentiation.
